Relevance of neurological assistance in the management of patients with Parkinson’s disease


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

The article presents a review devoted to the relevance of the neurological examination of patients with Parkinson’s disease (PD), as well as the most common causes of error diagnosis of PD, the reasons for hospitalization and mortality in PD.

Texto integral

Acesso é fechado

Sobre autores

E. Bril

FSBEIFPE RMACPE of RMH; Federal Neurological Center FMBC n.a. A.I. Burnazyan FMBA of Russia

Email: e.briH@inbox.ru
PhD, Associate Professor of Neurology; Head of the Federal Neurological Center

N. Fedorova

FSBEIFPE RMACPE of RMH

T. Kulua

FSBEIFPE RMACPE of RMH

O. Zimnyakova

Federal Neurological Center FMBC n.a. A.I. Burnazyan FMBA of Russia

M. Anikina

Federal Neurological Center FMBC n.a. A.I. Burnazyan FMBA of Russia

Bibliografia

  1. Wirdefeldt K., Adami H., Cole P., Trichopoulos D. Epidemiology and etiology of Parkinson's disease: a review of the evidence. J. Eur. J. Epidemiol. 2011;26(Suppl. 1):S1-8.
  2. Левин О.С. Клиническая эпидемиология болезни Паркинсона. В кн.: Болезнь Паркинсона и расстройства движений: рук. для врачей: по матер. II Нац. Конгресса / Под ред. С.Н. Иллариошкина, О.С. Левина. М., 2011. С. 5-9
  3. Neurological disorders. Public health challenges. Chapter 2 Global burden of neurological disorders: estimates and projections. WHO., 2006. P. 27-40.
  4. Левин О.С., Федорова Н.В. Болезнь Паркинсона. 4-е изд. М., 2014. 384 с.
  5. Postuma R., Berg D., Stern M., Poewe W., Olanow C.W., Oertel W., Obeso J., Marek K., Litvan I., Lang A.E., Halliday G., Goetz C.G., Gasser T., Dubois B., Chan P., Bloem B.R., Adler C.H., Deuschl G. MDS Clinical Diagnostic Criteria for Parkinson’s Disease. Mov. Disord. 2015;30(12):1591-601.
  6. Marshall V.L., Reininger C.B., Marquardt M., Patterson J., Hadley D.M., Oertel W.H., Benamer H.T., Kemp P., Burn D., Tolosa E., Kulisevsky J., Cunha L., Costa D., Booij J., Tatsch K., Chaudhuri K.R., Ulm G., Pogarell O., H ffken H., Gerstner A., Grosset D.G. Parkinson’s Disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European Multicenter Study with repeat [123I] FP-CITSPECT. Mov. Disord. 2009;24(4):500-8.
  7. Meara J., Bhowmick B.K., Hobson P Accuracy of diagnosis in patients with presumed Parkinson's disease. Age Ageing. 1999;28:99-102.
  8. Jellinger K. The pathology of parkinsonism. In: Movement Disorders 2. C.D. Marsden, S. Fahn -Butterworth, 1987. P. 124-65.
  9. Schrag A., Ben Shlomo Y., Quinn N. How valid is the clinical diagnosis of Parkinson's disease in the community? J. Neurol. Neurosurg. Psychiatry. 2002;73:529-34.
  10. Кривонос О.В., Смоленцева И.Г., Амосова Н.А. Эпидемиологический мониторинг заболеваемости при болезни Паркинсона. Саратовский научно-медицинский журнал. 2013;9(4):873-77.
  11. Раздорская В.В.,Воскресенская О.Н., Юдина Г.К. Диагностическая надежность амбулаторного звена неврологической помощи пациентам с болезнью Паркинсона. Саратовский научномедицинский журнал. 2012;8(2):513-17.
  12. Willis A.W., Schootman M., Evanoff B.A., Perlmutter J.S. Neurologist care in Parkinson disease. A utilization, outcomes, and survival study Neurology. 2011;77:851-57.
  13. Swarztrauber K., Vickrey B.G. Do neurologists and primary care physicians agree on the extent of specialty involvement of patients referred to neurologists? J. Gen. Intern. Med. 2004;19:654-61.
  14. Bloem B.R., Stocchi F. Move for change part I: a European survey evaluating the impact of the EPDA Charter for People with Parkinson's disease. Eur. J. Neurol. 2012;19:402-10.
  15. Harris-Hayes M., Willis A.W., Klein S.E., Czuppon S. Relative Mortality in U.S. Medicare Beneficiaries with Parkinson Disease and Hip and Pelvic Fractures. J. Bone Joint Surg. Am. 2014;96:e27(1-7).
  16. Safarpour D., Thibault D.P., DeSanto C.L., Boyd C.M., Dorsey E.R., Racette B.A., Willis A.W. Nursing home and end-of-life care in Parkinson disease. Neurology. 2015;85:413-19.
  17. Willis A.W., Schootman M., Tran R., Kung N., Evanoff B.A., Perlmutter J.S., Racette B.A. Neurologist-associated reduction in PD-related hospitalizations and health care expenditures. Neurology. 2012;79:1774-80.
  18. Willis A.W., Schootman M., Kung N., Evanoff B.A., Perlmutter J.S., Racette B.A. Predictors of survival in Parkinson disease. Arch. Neurol. 2012;69(5):601-7.
  19. Clarke C.E. Does levodopa therapy delay death in Parkinson's disease: a review of the evidence. Mov. Disord. 1995;10:250-56.
  20. Clarke C.E. Mortality from Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 2000; 68:254-55.
  21. Poewe W.H., Wenning G.K. The natural history of Parkinson's disease. Ann. Neurol. 1998; 44:S1-9.
  22. de Lau L.M., Breteler M.M. Epidemiology of Parkinson's disease. Lancet Neurol. 2006; 5:525-35.
  23. Diem-Zangerl A.,Seppi K., Wenning G.K., Trinka E., Ransmayr G., Oberaigner W., Poewe W. Mortality in Parkinson's disease: a 20-year follow-up study. Mov. Disord. 2009; 24:819-25.
  24. Rajput A.H., Uitti R.J., Rajput A.H. Timely levodopa (LD) administration prolongs survival in Parkinson's disease. Parkinsonism Relat. Disord. 1997;3:159-65.
  25. Tanner C.M., Goldman S.M. Epidemiology of Parkinson's disease. Neurol. Clin. 1996; 14:317-35.
  26. Marttila R.J., Rinne U.K. Progression and survival in Parkinson's disease. Acta Neurol. Scand. 1991;84:24-8.
  27. Macleod A.D., Taylor K.S., Counsell C.E. Mortality in Parkinson's Disease: A Systematic Review and Meta-analysis. Movement Disorders. 2014;29(13):1615-22.
  28. Jill E., Elaine B., McDade L. Dysphagia and dementia in subjects with Parkinson's disease. Dysphagia. 1995;10(Issue 3):160-64.
  29. Robbins J.A., Logemann J.A., Kirshner H.S. Swallowing and speech production in Parkinson's disease. Ann. Neurol. 1986;19:283-87.
  30. Hely M.A., Morris J.G., Traficante R., Reid W.G., O'Sullivan D.J., Williamson PM. The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years. J. Neurol. Neurosurg. Psychiatry. 1999; 67(3):300-7.
  31. Akbar U., Dham B., He Y., Hack N., Wu S., Troche M., Tighe P., Nelson E., Friedman J., Okun M. Incidence and mortality trends of aspiration pneumonia in Parkinson's disease in the United States, 1979e2010. Parkinsonism. Relat. Disord. 2015;21:1082-86.
  32. Смоленцева И.Г., Чупина Л.П., Кривонос О.В., Амосова Н.А. Причины госпитализаций и смерти при болезни Паркинсона по результатам 3-летнего проспективного исследования. Клиническая неврология. 2013; 2:6-10.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies